Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Effector Therapeutics Provides Positive Clinical Data Update For Zotatifin And General Corporate Update

Jan 5 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS PROVIDES POSITIVE CLINICAL DATA
UPDATE FOR
ZOTATIFIN AND GENERAL CORPORATE UPDATE
    * EFFECTOR THERAPEUTICS INC - ZOTATIFIN CONTINUES TO SHOW
FAVORABLE ACTIVITY PROFILE
    * EFFECTOR THERAPEUTICS INC - EFFECTOR TO FOCUS ON
FRONT-LINE
PD-L1 ≥ 50% COHORT OF KICKSTART TRIAL WITH TOMIVOSERTIB IN
NON-SMALL CELL LUNG CANCER
    * EFFECTOR THERAPEUTICS INC - COMPLETED ENROLLMENT IN THIRD
AND
FINAL COHORT IN OUR PHASE 1B STUDY WITH ZOTATIFIN IN COVID-19

Source text for Eikon:  ID:nGNX7vRSNK 
Further company coverage:  EFTR.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Effector Therapeutics

See all news